Ticker > Company >

3B Blackbio Dx share price

3B Blackbio Dx Ltd.

BSE: 532067 SECTOR: Pesticides & Agrochemicals  36k   148   23

1679.95
-10.75 (-0.64%)
BSE: Today, 12:54 PM

Price Summary

Today's High

₹ 1725.7

Today's Low

₹ 1656.2

52 Week High

₹ 1910

52 Week Low

₹ 660

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1441.85 Cr.

Enterprise Value

1387.68 Cr.

No. of Shares

0.86 Cr.

P/E

33.42

P/B

5.77

Face Value

₹ 10

Div. Yield

0.18 %

Book Value (TTM)

₹  291.4

CASH

54.88 Cr.

DEBT

0.71 Cr.

Promoter Holding

41.29 %

EPS (TTM)

₹  50.27

Sales Growth

489.49%

ROE

27.15 %

ROCE

36.55%

Profit Growth

1484.18 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year489.49%
3 Year70.15%
5 Year42.38%

Profit Growth

1 Year1484.18%
3 Year171.04%
5 Year140%

ROE%

1 Year27.15%
3 Year23.5%
5 Year16.36%

ROCE %

1 Year36.55%
3 Year26.96%
5 Year18.89%

Debt/Equity

0.0031

Price to Cash Flow

50.65

Interest Cover Ratio

409.1239

CFO/PAT (5 Yr. Avg.)

0.898673529961256

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 41.29 0.00
Jun 2024 41.29 0.00
Mar 2024 41.29 0.00
Dec 2023 38.43 0.00
Sep 2023 38.43 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 171.044467530287% for the Past 3 years.
  • The company has shown a good revenue growth of 70.1506952808761% for the Past 3 years.
  • The company has significantly decreased its debt by 1.3147 Cr.
  • Company has been maintaining healthy ROE of 23.5015545214614% over the past 3 years.
  • Company has been maintaining healthy ROCE of 26.9641151933686% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 409.1239.
  • Company’s PEG ratio is 0.0260063185866766.
  • Company has a healthy liquidity position with current ratio of 6.7926.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 13.129922165485.

 Limitations

  • Company has contingent liabilities of 193.3101 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 18.57 16.96 21.99 17.51 26.57
Total Expenditure 9.9 7.36 11.83 7.17 11.48
Operating Profit 8.66 9.6 10.16 10.34 15.09
Other Income 2.75 2.47 4.15 3.68 3.43
Interest 0.04 0.02 0.04 0.01 0.04
Depreciation 0.22 0.2 0.27 0.22 0.22
Exceptional Items 0 0 0 0 0
Profit Before Tax 11.15 11.85 14 13.79 18.27
Tax 2.67 2.64 4.94 3.06 4.13
Profit After Tax 8.48 9.21 9.06 10.73 14.14
Adjusted EPS (Rs) 9.9 10.75 10.57 12.53 16.51

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 13.51 14.36 15.52 12 70.72
Total Expenditure 13.75 15.57 16.76 12.93 35.62
Operating Profit -0.24 -1.21 -1.23 -0.93 35.11
Other Income 1.4 3.72 10.09 4.09 12.32
Interest 0.33 0.23 0.11 0.2 0.11
Depreciation 0.22 0.2 0.29 0.3 0.87
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.61 2.08 8.46 2.65 46.44
Tax 0 0.37 0.46 0.49 12.23
Net Profit 0.61 1.72 8.01 2.16 34.21
Adjusted EPS (Rs.) 0.82 2.29 10.69 2.88 39.93

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 7.49 7.49 7.49 7.49 8.57
Total Reserves 13.29 15.16 16.44 16.73 219.21
Borrowings 1.46 1.02 0.84 0.91 0.71
Other N/C liabilities 0.65 0.62 0.91 0.88 4.31
Current liabilities 5.27 4.6 5.93 3.84 17.02
Total Liabilities 28.17 28.89 31.6 29.86 249.82
Assets
Net Block 1.97 1.98 3.23 3 6.53
Capital WIP 0.2 0.13 0.11 0.09 0
Intangible WIP 0 0 0 0 0
Investments 3.6 3.6 3.6 3.6 127.7
Loans & Advances 0.23 0.26 0.27 0.23 0
Other N/C Assets 0 0 0 0 0
Current Assets 22.17 22.92 24.4 22.94 115.59
Total Assets 28.17 28.89 31.6 29.86 249.82
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.61 2.08 8.46 2.65 46.44
Adjustment 0.55 0.43 0.4 0.5 -5.15
Changes in Assets & Liabilities -0.06 0.68 -0.71 -1 -1.99
Tax Paid 0 -0.4 -0.17 -0.51 -10.84
Operating Cash Flow 1.1 2.79 7.98 1.65 28.47
Investing Cash Flow -2.45 -0.17 -1.52 -0.02 -20.32
Financing Cash Flow 1.42 -1.59 -6.31 -2.57 -3.62
Net Cash Flow 0.07 1.02 0.14 -0.95 4.53

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 38.43 38.43 41.29 41.29 41.29
2b blackbio s.l. spain - - - 2.81 2.81
anamika dubey 0.29 0.29 0.26 0.26 0.26
dhirendra dubey 5.21 5.21 8.44 8.44 8.44
madhulika dubey 0.39 0.39 0.34 0.34 0.34
mahesh kumar upadhyay 0.33 0.33 0.29 0.29 0.29
mithala laboratories priv... 10.93 10.93 9.56 9.56 9.56
mithla dubey 14.12 14.12 12.35 12.35 12.35
nikhil kuber dubey 3.66 3.66 4.17 4.17 4.17
rajesh kumar dubey 0.50 0.50 0.44 0.44 0.44
ram kuber dhirendra kumar... 2.59 2.59 2.27 2.27 2.27
sanjay kumar dubey 0.07 0.07 0.06 0.06 0.06
santosh kumar dubey 0.35 0.35 0.31 0.31 0.31
2b blackbio, s.l. spain - - 2.81 - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 61.57 61.57 58.71 58.71 58.71
ark global emerging compa... 2.37 2.37 2.14 2.37 2.36
dalmus performance focuse... - 1.18 1.55 1.64 1.64
investor education and pr... - 0.48 0.41 0.41 0.41
maj navraj singh grewal 2.99 2.99 2.61 2.61 2.61
own infracon private limi... 5.93 5.93 5.18 5.18 4.92
prateek goel - - 5.20 5.20 5.18
sandeep kapadia 1.13 1.15 1.00 1.00 1.00
shalu aggarwal 1.07 1.33 1.43 1.17 1.05
varun daga 5.99 5.99 5.24 5.24 5.24
amit chander 1.03 1.03 - - -
investor education and pr... 0.50 - - - -
lenus finvest private lim... 1.04 - - - -

Ratings & Research Reports

Company Presentations

Company News

3B BlackBio Dx informs about loss of share certificate 17 Aug, 3:45 PM 3B Blackbio Dx - Quaterly Results 12 Aug, 3:43 PM 3B Blackbio Dx - Quaterly Results 12 Aug, 3:43 PM 3B Blackbio Dx - Quaterly Results 12 Aug, 3:43 PM 3B BlackBio Dx informs about issue of duplicate share certificate 13 Mar, 3:39 PM 3B Blackbio Dx - Quaterly Results 9 Feb, 2:30 PM 3B Blackbio Dx - Quaterly Results 9 Feb, 2:30 PM 3B Blackbio Dx - Quaterly Results 9 Feb, 2:30 PM 3B Blackbio Dx’s Agro-chemical division receives export order worth Rs 1.59 crore 11 Jan, 10:30 AM Kilpest India informs about disclosure 13 Oct, 10:26 AM Kilpest India informs about annual general meeting 29 Aug, 4:27 PM Kilpest India informs about press release 26 Aug, 3:14 PM Kilpest India - Quaterly Results 11 Aug, 2:40 PM Kilpest India - Quaterly Results 11 Aug, 2:40 PM Kilpest India informs about confirmation certificate 6 Jul, 5:18 PM Kilpest India informs about analyst meet 20 Jun, 5:07 PM Kilpest India - Quaterly Results 29 May, 2:45 PM Kilpest India - Quaterly Results 14 Feb, 2:20 PM Kilpest India informs about closure of trading window 30 Dec, 3:51 PM Kilpest India’s arm signs non-binding LoI to acquire 100% shares of European based company 30 Nov, 9:49 AM Kilpest India’s arm bags export order 18 Aug, 3:43 PM Kilpest India - Quaterly Results 10 Aug, 2:47 PM Kilpest India informs about disclosure of related party transactions 7 Jun, 4:54 PM Kilpest India - Quaterly Results 27 May, 2:38 PM Kilpest India’s arm completes acquisition of 70% stake in HS Biolabs 29 Mar, 11:57 AM Kilpest India informs about investor's presentation 9 Feb, 4:43 PM Kilpest India - Quaterly Results 9 Feb, 2:38 PM Kilpest India - Quaterly Results 9 Feb, 2:38 PM Kilpest India - Quaterly Results 9 Feb, 2:38 PM Kilpest India informs about proceedings of 49th AGM 23 Sep, 3:49 PM Kilpest India informs about business update 1 Jun, 3:45 PM Kilpest India sells 16,54,000 Covid19 RT-PCR test kits in April 2021 3 May, 10:13 AM Kilpest India sells 2,67,200 COVID-19 RTPCR tests in February 2021 2 Mar, 11:46 AM Kilpest India sells 4.93 lakh COVID-19 RT-PCR Tests in January 2 Feb, 10:09 AM Kilpest India sells 7.82 lakh COVID-19 RT-PCR Tests in December 2 Jan, 10:47 AM Kilpest India informs about demise of chairman cum MD 7 Dec, 10:18 AM Kilpest India informs about business updates 1 Dec, 4:09 PM Kilpest India sells 6.10 lakh COVID-19 RT-PCR Tests in November 1 Dec, 3:49 PM Kilpest India sells 9.09 lakh COVID-19 tests in October 3 Nov, 11:42 AM Kilpest India’s arm extends agreement with HS Biolabs Manchestor 12 Oct, 9:31 AM Kilpest India sells 8.68 lakh Covid-19 RT-PCR tests in September 3 Oct, 10:30 AM Kilpest India sells 4,22,000 Covid-19 RT-PCR tests in August 3 Sep, 4:32 PM Kilpest India sells 6,66,000 Covid19 test kit in June 3 Jul, 3:17 PM Kilpest India gets USFDA’s grant for multiplex real-time PCR test 19 Jun, 4:31 PM Kilpest India bags multiple orders for coronavirus test kit from HITES 11 Jun, 9:21 AM Kilpest India informs about board meeting 8 Jun, 10:31 AM

3B Blackbio Dx Stock Price Analysis and Quick Research Report. Is 3B Blackbio Dx an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

3B Blackbio Dx stock price today is Rs 1679.95. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse 3B Blackbio Dx . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). 3B Blackbio Dx has a PE ratio of 33.4209332675505 which is high and comparatively overvalued .

  • Share Price: - The current share price of 3B Blackbio Dx is Rs 1679.95. One can use valuation calculators of ticker to know if 3B Blackbio Dx share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. 3B Blackbio Dx has ROA of 24.4663 % which is a good sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. 3B Blackbio Dx has a Current ratio of 6.7926 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. 3B Blackbio Dx has a ROE of 27.1535 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. 3B Blackbio Dx has a Debt to Equity ratio of 0.0031 which means that the company has low proportion of debt in its capital.

  • Sales growth: - 3B Blackbio Dx has reported revenue growth of 489.4887 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of 3B Blackbio Dx for the current financial year is 49.6416376220405 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for 3B Blackbio Dx is Rs 3 and the yield is 0.1774 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of 3B Blackbio Dx is Rs 50.2664 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of 3B Blackbio Dx in Ticker for free. Also, one can get the intrinsic value of 3B Blackbio Dx by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about 3B Blackbio Dx
X